newer company with products to enable minimally invasive lower back surgery. Losing money but losses decreasing as sales grow. Large insider buys at almost twice the current price. Breakeven will be a while - most likely 2016 or later (a WAG).
Your thoughts? Also what do you think about inviting baldingcontrarian to this board? His peix play is working out.
I've checked BAXS with the insider purchase last month but passed because of the extent of losses. I did see the news release this morning though. Again, I am just hesitant on these types of companies in the bio field.
"Also what do you think about inviting baldingcontrarian to this board? His peix play is working out. "